Stifel Nicolaus Remains a Buy on 908 Devices (MASS)
TipRanksMar 6 07:36 ET
Stephens & Co. Reiterates Overweight on 908 Devices, Maintains $14 Price Target
BenzingaSep 25, 2023 09:50 ET
908 Devices Analyst Ratings
BenzingaSep 25, 2023 09:49 ET
908 Devices (MASS) Receives a Buy From SVB Securities
TipRanksMar 8, 2023 23:07 ET
908 Devices Analyst Ratings
Benzinga Analyst RatingsFeb 7, 2023 05:03 ET
Stephens & Co. Initiates Coverage On 908 Devices With Overweight Rating, Announces Price Target of $14
Benzinga Real-time NewsFeb 7, 2023 05:03 ET
Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), 908 Devices (MASS) and Privia Health Group (PRVA)
TipRanksJan 18, 2023 07:55 ET
SVB Securities Sticks to Its Buy Rating for 908 Devices (MASS)
TipRanksJan 6, 2023 11:30 ET
SVB Securities Adjusts 908 Devices' Price Target to $20 From $30, Keeps Outperform Rating
MT NewswiresJan 6, 2023 10:59 ET
908 Devices Analyst Ratings
Benzinga Analyst RatingsJan 6, 2023 09:08 ET
SVB Leerink Maintains Outperform on 908 Devices, Lowers Price Target to $20
Benzinga Real-time NewsJan 6, 2023 09:08 ET
SVB Securities Keeps Their Buy Rating on 908 Devices (MASS)
TipRanksNov 15, 2022 07:45 ET
908 Devices Analyst Ratings
Benzinga Analyst RatingsNov 15, 2022 04:03 ET
SVB Leerink Maintains Outperform on 908 Devices, Lowers Price Target to $25
Benzinga Real-time NewsNov 15, 2022 04:01 ET
SVB Securities Keeps Their Buy Rating on 908 Devices (MASS)
TipRanksAug 10, 2022 23:20 ET
No Data
No Data